Cryo Cell International Inc (CCEL) Institutional Ownership

Ownership Summary

The institutional landscape for Cryo Cell International Inc (NYSE:CCEL) includes 20 filers as of the latest reporting cycle ending September 2025.

• Institutional ownership in Cryo Cell International edged up to 12.3% in September 2025, compared to 12.1% in June 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 4.01%, with a year-over-year an increase of 42.86% in the count of filers.
• A review of institutional activity for Cryo Cell International shows 7 of 20 filers increasing their positions, while 6 reduced their stake, and 7 remained unchanged.
• The aggregate institutional position in Cryo Cell International now stands at 988.34K shares as of September 2025, after investors increased their holdings (up by 38.14K shares quarter on quarter which is up 86.99K shares year over year).
• The top institutional stake in Cryo Cell International as of September 30, 2025 belongs to HAMILTON LANE ADVISORS LLC, which owns 409.73K shares, or 5.09% of the company.
• Among the most significant buyers of Cryo Cell International during September 2025 were VANGUARD GROUP INC (21.18K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.06K), RENAISSANCE TECHNOLOGIES LLC (10.18K), GEODE CAPITAL MANAGEMENT, LLC (7.58K), Tower Research Capital LLC (TRC) (778).
• Leading sellers of Cryo Cell International stock in September 2025 included NORTHERN TRUST CORP (8.30K), CITADEL ADVISORS LLC (3.17K), OSAIC HOLDINGS, INC. (744), BlackRock, Inc. (440), BANK OF AMERICA CORP /DE/ (34).
• The top 10 institutional holders of Cryo Cell International for the quarter ending September 2025 included HAMILTON LANE ADVISORS LLC (409.73K), SFI Advisors, LLC (165.30K), VANGUARD GROUP INC (150.99K), MassMutual Private Wealth & Trust, FSB (111.03K), GEODE CAPITAL MANAGEMENT, LLC (53.42K), NORTHERN TRUST CORP (28.72K), Cerity Partners LLC (19.56K), BlackRock, Inc. (12.35K), CITADEL ADVISORS LLC (11.40K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (11.06K).